Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|November 5, 2020
Pharmacology-Guided Rule-Based Adaptive Dose Escalation in First-in-Human StudiesEwoud-Jan van Hoogdalem, Mattheus Thijs van Iersel, Erica Winter, et al.
Journal of Exposure Science & Environmental Epidemiology|December 7, 2007
Assessment of exposure in epidemiological studies: the example of silica dustDirk Dahmann, Dirk Taeger, Martin Kappler, et al.
Biometrical Journal. Biometrische Zeitschrift|December 22, 2021
Robust group sequential designs for trials with survival endpoints and delayed responsePranab Ghosh, Robin Ristl, Franz König, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 14, 2020
Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trialJoão Pedro Ferreira, Abhinav Sharma, Cyrus Mehta, et al.
American Heart Journal|September 11, 2020
Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitusMalik Elharram, Abhinav Sharma, William White, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Fitness cost of chromosomal drug resistance-conferring mutationsPeter Sander, Burkhard Springer, Therdsak Prammananan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 1, 2005
Decreased bone mineral density in patients with neurofibromatosis 1Marga Lammert, Martin Kappler, Victor-Felix Mautner, et al.
Cancer Research|January 11, 2007
Allelic loss in a minimal region on chromosome 16q24 is associated with vitreous seeding of retinoblastomaSandrine Gratias, Harald Rieder, Reinhard Ullmann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2021
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndromeXavier Rossello, João Pedro Ferreira, Francisca Caimari, et al.
Journal of Clinical Immunology|July 17, 2017
A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune DeficiencyGergely Krivan, Ludmila Chernyshova, Larysa Kostyuchenko, et al.
Pageof 5